Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Breast cancer
Closed
Phase 1/2
This trial is looking at a new drug called taselisib (also known as GDC-0032) and a hormone therapy drug called tamoxifen for advanced breast cancer. It is for women:
Who have already had hormone therapy and whose cancer has grown into surrounding tissue (is locally advanced) or has spread to another part of their body
Whose cancer is also and
Recruitment start: 15 December 2014
Recruitment end: 25 May 2020
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Richard Baird
Cambridge University
Cambridge University Hospitals NHS Foundation Trust
Experimental Cancer Medicine Centre (ECMC)
Genentech
Netherlands Cancer Institute
NIHR Clinical Research Network: Cancer
Vall d’Hebron Institute of Oncology
Last reviewed: 20 August 2020
CRUK internal database number: 12879
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
